Search Results

CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.

• Authors : Vahidian, Fatemeh^1,2 (AUTHOR) ; Lamaze, Fabien C.¹ (AUTHOR) ; Bouffard, Cédrik^1,2 (AUTHOR)

• Source: Cancers. Feb2024, Vol. 16 Issue 4, p708. 13p.

Record details

Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor.

• Authors : Guo, Jia^1,2 ; Yang, Qi^1,2 ; Jiang, Qi¹

Subjects: *THERAPEUTIC use of antineoplastic agents; *NASOPHARYNX cancer; *PROGRAMMED cell death 1 receptors

• Source: Nutrients. Oct2023, Vol. 15 Issue 19, p4262. 19p.

Record details

Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.

• Authors : Zhou, Xiang¹ (AUTHOR); Hu, Yongquan² (AUTHOR); Sun, Hong³ (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Aug2023, Vol. 50 Issue 10, p3107-3115. 9p. 2 Color Photographs, 7 Charts, 2 Graphs.

Record details

Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study.

• Authors : Xie, Jingyuan¹ (AUTHOR); Chen, Mo² (AUTHOR); Han, Hedong¹ (AUTHOR)

• Source: Thoracic Cancer. May2023, Vol. 14 Issue 15, p1327-1338. 12p.

Record details

Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas.

• Authors : Sánchez-Canteli, Mario^1,2 (AUTHOR) ; Juesas, Luis¹ (AUTHOR); Garmendia, Irati^2,3 (AUTHOR)

Subjects: *SQUAMOUS cell carcinoma; *PROGRAMMED cell death 1 receptors; *PROGNOSIS

• Source: International Journal of Molecular Sciences. Oct2022, Vol. 23 Issue 19, p11559. 11p.

Record details

Triterpenoids of Rhus chinensis Supressed Colorectal Cancer Progress by Enhancing Antitumor Immunity and CD8 + T Cells Tumor Infiltration.

• Authors : Wang, Gang¹; Yu, Yang²; Li, Zi-Meng¹

Subjects: *PROGRAMMED cell death 1 receptors; *PROGRAMMED death-ligand 1; *HERBAL medicine

• Source: Nutrition & Cancer. 2022, Vol. 74 Issue 7, p2550-2564. 15p. 1 Diagram, 2 Charts, 5 Graphs.

Record details

Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications.

• Authors : Sun, Xuqi^1,2 (AUTHOR); Zhang, Qi^1,2 (AUTHOR); Mei, Jie³ (AUTHOR)

• Source: BMC Cancer. 3/19/2022, Vol. 22 Issue 1, p1-8. 8p.

Record details

Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study.

• Authors : Schad, Friedemann; Thronicke, Anja; Hofheinz, Ralf-Dieter

Subjects: RESEARCH funding; PROGRAMMED death-ligand 1; MULTIVARIATE analysis

• Source: Cancers; Apr2024, Vol. 16 Issue 8, p1609, 19p

Record details

Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer.

• Authors : Choo, Joan¹ (AUTHOR); Kua, Ley Fang² (AUTHOR); Soe, Mu Yar¹ (AUTHOR)

Subjects: *PROGRAMMED cell death 1 receptors; *T cells; *STOMACH cancer

• Source: Gastric Cancer. May2023, Vol. 26 Issue 3, p393-404. 12p.

Record details

Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer.

• Authors : Du, Zixuan^1,2 (AUTHOR); Yan, Derui^1,2 (AUTHOR); Li, Zhongyang³ (AUTHOR)

• Source: Journal of Oncology. 9/8/2020, p1-14. 14p.

Record details